Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 10.5610.988.726.2411.72

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.56 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202510.56
Mar202410.98
Mar20238.72
Mar20226.24
Mar202111.72

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 10.56
-3.83
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24
-46.76
Mar2021 11.72 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹134.8 Cr 3.2% 8% -51.1% Stock Analytics
ADANI ENTERPRISES ₹407,531.0 Cr -4.7% 1.6% 24.5% Stock Analytics
AEGIS LOGISTICS ₹48,078.2 Cr 1.6% 29.6% 81.1% Stock Analytics
PREMIER ENERGIES ₹46,486.9 Cr -5.7% -2.1% -5% Stock Analytics
ADITYA INFOTECH ₹42,600.6 Cr -0% 1.4% NA Stock Analytics
REDINGTON ₹20,490.3 Cr -4.7% -5% -13.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

3.2%

8%

-51.1%

SENSEX

-1%

-0.9%

-7.5%


You may also like the below Video Courses